Both sublingual and injectable forms have shown benefits
Suelen aparecer en las primeras semanas y tienden a reducirse con el tiempo, especialmente con un ajuste progresivo de dosis
But keeping it off after you stop taking the drug can be a big challenge
The medication protocol is not prescribed for those with a BMI under 30, active eating disorders, gallbladder disease, history of substance abuse, very recent bariatric surgery, pancreatitis, thyroid cancer, or other specific exclusions
What about other GLP-1 drugs and SSRIs
Liraglutide exerts anti-catabolic effect in murine primary chondrocytes in vitro To explore the inhibitory effect of liraglutide on the production of catabolic mediators, IL-1-stimulated chondrocytes were cultured with 2 ng/mL of IL-1 and 10 ascending doses (6.6, 13.3, 26.6, 53.1, 106.3, 212.5, 425, 850 nM, 1.7 and 3.4 M) of liraglutide for 24 h for IC 50 determination